Ginkgo Bioworks logo

Ginkgo Bioworks

DNA | NYSE
Chart Builder DCF Calculator
$8.50
-$1.11 (-11.55%)
At close: Nov 16, 2026, 4:00 PM ET
$8.54
+$0.04 (+0.47%)
After-hours: Nov 16, 2026, 7:41 PM ET
-11.55%

Rating

Updated: Nov 16, 2026
37
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #613/1021 (Top 60%)

Key Statistics

Market Data

Market Cap $551.01M
1D Range
8.35 9.30
52W Range
5.48 14.98

Valuation (TTM)

PE -2.02
PB 1.40
EV/EBITDA -3.03

Valuation (NTM)

Forward PE N/A
Forward PEG 0.10
Price Target $5.00
Loading financial charts...

Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The co...

Sector Healthcare
Industry Biotechnology
Employees 485
IPO Date Apr 19, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.64
Beat +5.59%
REV
$27.71M
Beat +28.89%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$5.00
Downside
-41.18%
Buy (0)
Hold (1)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.